Advertisement Biovail names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biovail names new CFO

Biovail Corporation, a specialty pharmaceutical company, has appointed Peggy Mulligan as its new CFO, effective September 3, 2008.

Ms Mulligan succeeds Adrian Saldanha, who had been serving as Biovail’s interim CFO.

Ms Mulligan was most recently a principal at Priiva Consulting, a game theory consulting practice. Prior to that, Ms Mulligan served as executive vice president, CFO and treasurer of Linamar from 2005 to 2007.

Bill Wells, CEO of Biovail, said: “We are delighted to have someone with Peggy’s skills and experience joining our team. Her impressive suite of financial, information technology and management capabilities developed over a distinguished career makes her the ideal candidate to lead our finance organization.”